Proteasome subunit beta type-5 — Drug Target

All drugs that target Proteasome subunit beta type-5 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Proteasome Inhibitor [EPC] · Proteasome Inhibitor

Marketed (2)

• Kyprolis · Amgen · Proteasome Inhibitor [EPC] · Oncology
  Kyprolis works by blocking the proteasome, a complex that breaks down proteins in cells.
• Ninlaro · Takeda · Proteasome Inhibitor · Oncology
  Ninlaro blocks the action of proteasomes, which are cellular complexes that break down and recycle proteins.